参考文献/References:
[1] Sinkovics JG,Horvath JC. Newcastle disease virus (NDV):brief history of its oncolytic strains [J]. J Clin Viro,2000,16(1):115.
[2] Zeng J,Fournier P,Schirrmacher V. Induction of interferonalpha and tumor necrosis factorrelated apoptosisinducing ligand in human blood mononuclear cells by hemagglutininneuraminidase but not F protein of Newcastle disease virus[J].Virology,2002,297(1):19–30.
[3] Bazzoni F and Beutler B. The tumor necrosis factor ligand and receptor families[J].New England J Med,1996,334(26):17171725.
[4] Cassel WA,Murray DR. Treatment of stageⅡmalignant melanoma patients with a Newcastle disease virus oncolysate [J]. Nat Immun Cell Growth Regul,1988,7(56):351352.
[5] Johnson N,Letshwenyo M,Baipoledi EK,et al. Molecular epidemiology of rabies on Botswana:a comparison between antibody typing and nucleotide sequence phylogeny [J].Vet Microbiol,2004,101(1):3138.
[6] Ge J,Wang X,Tao L,et al. Newcastle disease virusvectored rabies vaccine is safe,highly immunogenic,and provides longlasting protection in dogs and cats [J],J Virol ,2011,85(16):8241–8252.
[7] Thoulouze MI,Lafage M,Yuste VJ,et al.High level of Bcl2 counteracts apoptosis mediated by a live rabies virus vaccine strain and induces longterm infection [J]. Virology 2003,314(2):549561.
[8] Dietzschold ,B,Schnell M,Koprowski H. Pathogenesis of rabies[J].Curr Top Microbiol Immunol,2005,292:45–56.
[9] Gaudin Y,Ruigrok RW,Knossow M ,et al. LowpH conformational changes of rabies virus glycoprotein and their role in membrane fusion [J]. J Virol,1993,67(3):1365–1372.〖ZK)〗
[10] Elankumaran S,Rockemann D,Samal SK. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspasedependent pathways of cell death [J]. J Virol,2006,80 (15):75227534.
相似文献/References:
[1]江茂琼,贾钰铭△,叶文静,等.MDSCs对肺癌小鼠CD8+T细胞及生存期的影响研究[J].陕西医学杂志,2019,(3):293.
JIANG Maoqiong,JIA Yuming,LI Ting,et al.Effect of MDSCs on CD8 T cells and survival time of lung cancer mice[J].,2019,(1):293.
[2]李君艳,陈国荣.肺癌患者凝血指标与临床特征的关系*[J].陕西医学杂志,2019,(6):718.
LI Junyan,CHEN Guorong..The relationships between coagulation indicators and clinic characterisitics of patients with lung cancer[J].,2019,(1):718.
[3]王 玲,申 鸿.癌胚抗原、糖类抗原、CA125、血管生成素、细胞角蛋白19片段及甲胎蛋白检测在肺癌诊断中的临床研究*[J].陕西医学杂志,2019,(8):1080.
WANG Ling,SHEN Hong..The value of tumor markers CEA,CA199,CA125,Ang-2,CYFRA211 and AFP in the diagnosis of lung cancer[J].,2019,(1):1080.
[4]韩 乐,陈文娟△,雷光焰,等.microRNA21、microRNA25在肺癌组织中的表达及意义*[J].陕西医学杂志,2019,(12):1596.
HAN Le,CHEN Wenjuan,LEI Guangyan,et al.Expression and significance of microRNA21 and microRNA25 in lung cancer tissues[J].,2019,(1):1596.
[5]王 勇,张 勇,白正忠△.单操作孔完全胸腔镜与传统三孔胸腔镜治疗老年肺癌疗效对比研究*[J].陕西医学杂志,2019,(12):1670.
[6]常瑞霞,可春梅.血小板相关参数和凝血指标在肺癌治疗中的变化及意义[J].陕西医学杂志,2021,50(5):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
CHANG Ruixia,KE Chunmei.Changes and significance of platelet-related parameters and coagulation indexes in treatment of lung cancer[J].,2021,50(1):610.[doi:DOI:10.3969/j.issn.1000-7377.2021.05.024]
[7]米卫国.负压引流管在单操作孔胸腔镜下肺癌根治术中的临床应用研究[J].陕西医学杂志,2021,50(7):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
MI Weiguo.Application effect of negative pressure drainage tube in patients undergoing radical surgery for lung cancer under single-port thoracoscopy[J].,2021,50(1):839.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.018]
[8]张玉琨,李 波,刘 静,等.迷走神经保护对胸腔镜下肺癌根治术后房颤发生的预防作用[J].陕西医学杂志,2021,50(10):1267.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.023]
[9]米 婷,王雅宁.气管镜下宏基因组学二代测序技术在肺癌鉴别诊断中的临床应用价值[J].陕西医学杂志,2022,51(4):437.[doi:DOI:10.3969/j.issn.1000-7377.2022.04.012]
[10]张军艳,谷 俊.程序性死亡配体1在肺癌组织中的表达及其与患者病理特征和疾病预后相关性研究[J].陕西医学杂志,2022,51(7):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]
ZHANG Junyan,GU Jun.Expression of programmed death ligand 1 in lung cancer tissues and its correlation with pathological characteristics and prognosis[J].,2022,51(1):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]